Original Article

Association between Epstein-Barr Virus and Classic Hodgkin Lymphoma in Jordan: A Comparative Study with Epstein-Barr Virus-associated Hodgkin Lymphoma in North America

Authors: Mohammad A. Vasef, MD, Manaf A. Ubaidat, MD, Hasan S. Khalidi, MD, Nidal M. Almasri, MD, Mousa Al-Abbadi, MD, Hassan Z. Annab, MD

Abstract

An association between Epstein-Barr virus and Hodgkin lymphoma has been shown in several parts of the world. The reported incidence of Epstein-Barr virus in Hodgkin lymphoma varies significantly from one country to another and ranges from <30% in Swedish patients to 100% in patients from Kenya. Using in situ hybridization for detection of Epstein-Barr virus-encoded RNA and immunohistochemistry for detection of Epstein-Barr virus latent membrane protein, we analyzed 28 cases of Hodgkin lymphoma from Jordan and 30 cases from the United States. Eight of 28 Jordanian cases and 9 of 30 North American cases were Epstein-Barr virus positive. Our studies show that the incidence of Epstein-Barr virus among Jordanian patients with Hodgkin lymphoma is similar to the rate in patients from the United States. This rate appears to be low to intermediate compared with rates in other parts of the world.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Weinreb M, Day PJ, Niggli F, et al. The role of Epstein-Barr virus in Hodgkin’s disease from different geographical areas. Arch Dis Child 1996; 74: 27–31.
 
2. Sheibani K, Tubbs RR. Enzyme immunohistochemistry: Technical aspects. Semin Diagn Pathol 1984; 1: 235–250.
 
3. Weiss LM, Chen YY, Liu XF, et al. Epstein-Barr virus and Hodgkin’s disease: A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259–1265.
 
4. Vasef MA, Kamel OW, Chen YY, et al. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin’s disease. Am J Pathol 1995; 147: 1408–1415.
 
5. Pathmanathan R, Prasad U, Chandrika G, et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx: Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355–1367.
 
6. Vasef MA, Ferlito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. Ann Otol Rhinol Laryngol 1997; 106: 348–356.
 
7. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt lymphoma. Lancet 1964; 1: 702–703.
 
8. Weiss LM, Chang KL. Association of the Epstein-Barr virus with hematolymphoid neoplasia. Adv Anat Pathol 1996; 3: 1–15.
 
9. Kvale G, Hoiby EA, Pedersen E. Hodgkin’s disease in patients with previous infectious mononucleosis. Int J Cancer 1979; 23: 593–597.
 
10. Weiss LM, Movahed LA, Warnke RA, et al. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 1989; 320: 502–506.
 
11. Wu TC, Mann RB, Charache P, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin’s disease. Int J Cancer 1990; 46: 801–804.
 
12. Uhara H, Sato Y, Mukai K, et al. Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin’s disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 1990; 81: 272–278.
 
13. Pinkus GS, Lones M, Shintaku IP, et al. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin’s disease. Mod Pathol 1994; 7: 454–461.
 
14. Enblad G, Sandvej K, Sundstrom C, et al. Epstein-Barr virus distribution in Hodgkin’s disease in an unselected Swedish population. Acta Oncol 1999; 38: 425–429.
 
15. Benharroch D, Brousset P, Goldstein J, et al. Association of the Epstein-Barr virus with Hodgkin’s disease in Southern Israel. Int J Cancer 1997; 71: 138–141.
 
16. Monterroso V, Zhou Y, Koo S, et al. Hodgkin’s disease in Costa Rica: A report of 40 cases analyzed for Epstein-Barr virus. Am J Clin Pathol 1998; 109: 618–624.
 
17. Bosch Princep R, Alvaro Naranjo T, Balanza Roure R, et al. Hodgkin’s disease: Etiopathogenic role of Epstein-Barr virus in Tarragona [in Spanish]. Med Clin (Barc) 2000; 114: 411–413.
 
18. Liu SM, Chow KC, Chiu CF, et al. Expression of Epstein-Barr virus in patients with Hodgkin’s disease in Taiwan. Cancer 1998; 83: 367–371.
 
19. Engel M, Essop MF, Close P, et al. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin’s lymphoma: Study of 47 South African cases. J Clin Pathol 2000; 53: 182–186.